The company's on -site demands, government departments responded on the spot!Chengdu Innovation Pharmaceutical Industry Construction Circle Construction Strong Chain Enterprise Symposium was held

"Now prefabricated buildings have become the construction trend of new factories. However, in the construction process of plant buildings in the biomedical industry, relevant provisions of prefabricated buildings often have a certain impact on the relevant special process processes" "" As a large number of people from outside the province are from outside provinces The leading talents of biomedical came to Chengdu. The needs of these talents in terms of settlement and children's education are worthy of attention. "" Due to the continuous scale of enterprises, the demand for industrial land is increased. I hope that relevant departments will give some support "...

On the morning of July 9, the Chengdu Innovation Pharmaceutical Industry Construction Circle Construction Circle Symposium was held in Pengzhou City. The representatives of 12 pharmaceutical companies from some districts (cities) and counties in Chengdu throwing the above topic on the spot. Focusing on the strong chain of the industry, the company representatives have talked about the business development status of the enterprise, and the desire to enter the "circle" is strong; many companies have proposed the bottlenecks in development.

At the scene, the relevant functional departments of the government responded to every problem raised by the enterprise. Participating companies also found the required "answer" from the response.

▲ Chengdu Innovation Pharmaceutical Industry Construction Circle Strong Chain Enterprise Symposium was held in Pengzhou

How to co -produce the factory building with the housing construction policy?

Enterprises expect research and development products to get greater attention

At today's symposium, 12 companies from Chengdu's pharmaceutical field attended the conference. Among these enterprises, there are many long -established companies, Kanghong Pharmaceutical, Olin Biological and other companies, as well as "potential stocks" such as Chengdu Haifeng Biological. Although they all come from the medical field, the segmentation of the entrepreneurial tracks where these participating companies are located are obvious. Some companies focus on the research and development of innovative drugs, some companies are targeting non -clinical effectiveness evaluations, and some companies have deeply cultivated high -end generic drug production.

"In the context of the country's vigorous development of prefabricated buildings, relevant policies have put forward 40%of the requirements for the proportion of prefabricated buildings in enterprise factories. The factory will have the industry's own specifications. I hope that the relevant departments will study this situation to help biomedical companies explore a model construction model that meets both production technology and meet the construction specifications of construction construction. "Chengdu Beite Pharmaceutical Co., Ltd. Liu Taotao, director of the company's public affairs, threw this problem in the speech.

"Who should respond to the demand of the company?" At the symposium, the host immediately asked. As soon as the words fell, someone immediately "received". During the implementation process, there is a "one matter, one discussion" rule. For some projects that are not suitable to adopt prefabricated buildings, as long as experts are demonstrated, the construction assembly rate of the building can be lowered in compliance conditions. The phenomenon, how much is the factories of pharmaceutical companies?

"I hope that the competent department of health and health can study solving the qualifications and vaccine access of related departments such as the emergency department, burns, surgery and other related departments in the medical and health system. Propaganda education. "Chengdu Olin Biotechnology Co., Ltd. made the above suggestions.

"According to the state's vaccine management measures, the medical institution undertakes the vaccination task, which is approved by the local health department. Regarding the propaganda of vaccine vaccination, it will continue to promote grass -roots health education work, and promote publicity through carrier such as vaccination points to enhance the awareness of ordinary people.

Heated discussions such as land protection and talent support policies

Innovation platforms and venture capital funds will help "build a strong chain"

Zhao Jian, vice chairman of Sichuan New Green Pharmaceutical Technology Development Co., Ltd., mentioned that with the development of R & D and manufacturing projects, the demand for corporate land use has expanded. In the long run, it will encounter the problem of insufficient land supply. Essence

In response to the demands put forward by Zhao Jian, the relevant person in charge of the Chengdu Planning and Natural Resources Bureau said: "After the scale of the enterprise is expanded, the demand for industrial land is often faced. Studies, under the premise of strictly abide by national policies, provide protection for enterprises. "

Chen Bo, chairman of Connota Biomedical Technology (Chengdu) Co., Ltd., hopes to give enterprises more support for high -level talents. The relevant person in charge of the Organization Department of the Chengdu Municipal Party Committee said that in recent years, in recent years, in accordance with the reality of economic and social development, Chengdu has continued to improve the talent policy, provided comprehensive support for various types of talents, and sincerely hoped that the enterprise actively declared the industry to build a strong chain talent plan for the establishment of the industry. This talent plan has emerged high -level talents in more industrial segments.

"I hope that the science and technology department will increase their efforts to support the establishment of a national disease animal experiment model resource library. I also hope that the competent health department will introduce policy to promote the construction of clinical research ward." Yu Yuan, deputy general manager of Chengdu Haifeng Biotechnology Co., Ltd., brought the above suggestions. She It is revealed that the company's new drug evaluation base is expected to be put into use during the year. "In fact, we can also provide non -clinical effective evaluation for companies present in the future."

Today's symposium, for the participating companies, in addition to the on -site confession, there is a major purpose of seeking wider business cooperation opportunities in the background of a strong chain of the construction circle.

"It is recommended to set up a Chinese medicine innovation alliance to attract companies that really have enthusiasm for research and development of Chinese medicine and have a certain amount of input and output. Through the influence of the alliance, it will accelerate the efficiency of industrial cooperation among enterprises and form a group development trend." In Sichuan Sichuan From the perspective of the deputy general manager of Everbright Pharmaceutical Co., Ltd., there are fewer technical research and development alliances in the field of Chinese medicine, and the breadth and depth of industrial cooperation are lacking. In response to the suggestions made by Shangqiang, the relevant person in charge of the Chengdu Science and Technology Bureau stated that it is building an innovation consortium to promote the joint research on the upstream and downstream of the leading enterprise joint industrial chain and the college colleges based on key core technologies. "At the same time, the cooperation between schools and enterprises is carried out to promote entrepreneurs entering the campus. Scientists enter the park and communicate through two -way interactive form." The relevant person in charge of the above said.

At the symposium, there were also topics such as capital investment, talent introduction, and skill training of talents facing in their own development. Regarding the bottlenecks facing enterprise development, Pei Yusheng, chairman of Chengdu Science and Technology Innovation Investment Group Co., Ltd., said that he will strengthen communication with Chengdu Pharmaceutical Enterprises, pay close attention to the development of the enterprise, and help Chengdu's innovative pharmaceutical industry development through the form of finance.

Red Star News reporter Ye Yan Song Jia asked

Edit Tan Wangyu

- END -